Pinnacle Associates’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,595
| Closed | -$69.4K | – | 870 |
|
|
2024
Q3 | $69.4K | Buy |
10,595
+370
| +4% | +$2.42K | ﹤0.01% | 787 |
|
|
2024
Q2 | $73.2K | Hold |
10,225
| – | – | ﹤0.01% | 799 |
|
|
2024
Q1 | $88.7K | Sell |
10,225
-370
| -3% | -$3.21K | ﹤0.01% | 818 |
|
|
2023
Q4 | $69.4K | Buy |
+10,595
| New | +$69.4K | ﹤0.01% | 801 |
|
|
2022
Q4 | – | Sell |
-68,600
| Closed | -$1.75M | – | 770 |
|
|
2022
Q3 | $1.75M | Sell |
68,600
-7,340
| -10% | -$187K | 0.04% | 307 |
|
|
2022
Q2 | $2.16M | Sell |
75,940
-2,465
| -3% | -$70K | 0.05% | 293 |
|
|
2022
Q1 | $2.77M | Buy |
+78,405
| New | +$2.77M | 0.05% | 291 |
|